Date	Event Title	Add to Calendar
02 Nov	Receipt of a favourable Commission Implementing Decision from the European Commission on the proposed transfer of the European Marketing Authorisation of Fortacin™ to Recordati	N/A
23 Oct	Receipt of €4 million from Recordati in respect of the Amended and Restated Licence Agreement becoming effective (on 3 October 2017)	N/A
03 Oct	Execution of: (i) the Amended and Restated Licence Agreement with Recordati; and (ii) the Amended Development, Manufacturing and Supply Agreement with Pharmaserve (North West) Limited	N/A
25 Aug	2017 Interim Results Announcement	N/A
02 Jun	2017 Annual General Meeting
28 Mar	2016 Annual Results Announcement	N/A

Date

Event Title

Add to Calendar

02 Nov

Receipt of a favourable Commission Implementing Decision from the European Commission on the proposed transfer of the European Marketing Authorisation of Fortacin™ to Recordati

N/A

23 Oct

Receipt of €4 million from Recordati in respect of the Amended and Restated Licence Agreement becoming effective (on 3 October 2017)

N/A

03 Oct

Execution of: (i) the Amended and Restated Licence Agreement with Recordati; and (ii) the Amended Development, Manufacturing and Supply Agreement with Pharmaserve (North West) Limited

N/A

25 Aug

2017 Interim Results Announcement

N/A

02 Jun

2017 Annual General Meeting